Marlton, NJ • Philadelphia, PA • Salt Lake City, UT
- CRI Worldwide
- Lifetree Clinical Research
- Directions Administration
- Directions Marlton
- Directions Philadelphia
- Directions Salt Lake City
- Study Volunteers
- Home
- About
- Clinical Research Services
- Quality Management Program
- Volunteer for a Study
- Actively Enrolling Clinical Trials
- About Clinical Trials
- Alzheimer's
- Bunionectomy
- Austin Bunionectomy
- Akin Bunionectomy
- Austin-Akin Bunionectomy
- Chlamydia Home Testing Kit
- Chronic Low Back Pain
- Depression
- Diabetic Peripheral Neuropathy
- Gonorrhea Home Testing Kit
- Hepatitis C
- Hypertension
- Migraine Headache
- Multiple Sclerosis
- Opioid Induced Constipation
- Osteoarthritis
- Prescription Medication Abuse
- Schizophrenia
- Shingles / Postherpeticneuralgia
- Wisdom Teeth Removal
- Autism Clinical Trial - Utah
- Bipolar Clinical Trial - Utah
- Schizophrenia Clinical Trial - Utah
- Tourette's Clinical Trial - Utah
- Back Pain Clinical Trial - Utah
- Contact Us
- Sitemap
- Abstracts
- PR
- Lynn R. Webster, MD, to Discuss Human Abuse Liability at DIA Annual Meeting
- CRI Lifetree to Share Pain Research Expertise at the American Pain Society’s Annual Scientific Meeting
- dr-lynn-r-webster-president-of-the-american-academy-of-pain-medicine
- come-together-for-the-cure
- FDA might tighten reins on Vicodin
- Autism in Utah - CRI Lifetree Autism Study featured on KSL
- CRI Lifetree to Conduct First-of-Kind Study to Investigate Genetic and Behavioral Markers in Addiction to Prescribed Pain Medications
- CRI Worldwide and Lifetree Clinical Research Announce New Company Name — CRI Lifetree
- Dr. Backonja added to the Best Doctors 2011-2012 database
- Lifetree Clinical Research Expands Research Capacity
- New Clinical Research Study for Patients Suffering from Opioid-Induced Constipation - Learn more about the KODIAC Study.
- Lifetree Clinical Research appoints New Vice President
- Dr. Lynn Webster quoted in NEKTAR® Phase 1 Study
- Nektar Initiates Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule
- Pinney Associates, Inc., and Lifetree Clinical Research Announce a Collaboration to Provide Human Abuse Liability Testing
- Dr. Lynn Webster's letter to the editor on Opioids and Deaths published in The New England Journal of Medicine
- CRI Acquires Lifetree Creating a Leading Specialized Research Organization.
- CRI Worldwide Acquires Lifetree Clinical Research® Creating One of the Most Highly Specialized Research Organizations in the Nation.
- Lifetree Expands Services to Include Sleep Studies.
- Lifetree Announces New Medical Director for Lifetree Center for Neuroscience Research
- Opioid safety is focus of $1 million-a-year educational initiative
- Dr. Lynn Webster published in the BMC Neurology Journal for study on treatment of Postherpetic Neuralgia.
- Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
- LIFETREE CLINICAL RESEARCH® TO PARICIPATE AT 13th WORLD CONGRESS ON PAIN
- Dr. Lynn Webster cited in PM&R - Strategies to Optimize Pain Management With Opioids While Minimizing Risk of Abuse
- Dr. Lynn Webster: Executive Profile & Biography - BusinessWeek
- Dr. Debra Hobbins elected to the Board of Directors of the International Nurses Society on Addictions for the term 2010-2012.
- Lifetree Clinical Research® Chief Medical Director to be Featured on Discovery Channel Continuing Medical Education Program
- Lifetree Clinical Research® and Pain Clinic Chief Medical Director to Present in Dia Webinar
- Lifetree Clinical Research® CEO and co-founder named to Alzheimer’s Association, Utah Chapter Board of Directors
- Lifetree Clinical Research® to exhibit at 29th Annual Scientific Meeting of the American Pain Society
- Lifetree Clinical Research’s Medical Director forms new pain clinic for patients suffering from addiction
- 11th Annual Phase I Clinical Trials 23-24 February 2010
- To Help Healing, Doctors Pay More Attention To Pain
- Lifetree, in concert with Alltranz, has been awarded a $4MM NIH grant to investigate clinical treatments for THC addiction and withdrawal
- Lifetree Clinical Research® presents new prescription drug abuse study findings to pain medicine industry
- Lifetree Clinical Research® expands Lifetree Center for Neuroscience Research team Salt Lake-based company adds psychiatrist to staff
- Lifetree Clinical Research's Dr. Lynn R. Webster, MD Achieves Highly Statistical Significant Results
- Lifetree Clinical Research® offers Human Experimental pain models for clients
- Lifetree Clinical Research® presents new prescription drug abuse study findings to pain medicine industry
- Lifetree Clinical Research recognized as one of Inc. Magazine’s 5,000 fastest growing companies
- Lifetree Clinical Research® has been named to Utah Business's 2008 Fast 50, highlighting 50 of the fastest growing companies in Utah.
- Lifetree Clinical Research expands, now offers Bioanalytical services
- Lifetree Clinical Research President, Alice Jackson - One of Utah's Top Women to Watch
- Lifetree Clinical Research hires new clinical research pharmacist
- Elite Pharmaceuticals, Inc. to Present Clinical Data at the American Academy of Pain Medicine’s 24th Annual Meeting
- Lifetree Clinical Research's Lynn R. Webster Elected as American Academy of Pain Medicine Director-at-Large
- New Findings Show Pain Medications May Cause Sleep Apnea
- Pain patients are at risk for sleep apnea
- Algorithm determines with 95 percent confidence whether patients take pain medication as prescribed, independent study finds
- Lifetree Clinical Research now utilizing new technology to evaluate the abuse liability of test medications
- Lifetree Clinical Research facilitates bringing new drugs
- Lifetree Clinical Research expands facilities
- Lifetree Clinical Research and pain clinic pharmacist publishes article in the Journal of Family Practice
- New reference book helps Opioid prescribers assess patient risk of Opioid abuse, avoid abuse and diversion, and protect themselves legally
- Clinical research company, led by female CEO, essential in aiding bio and pharma companies to get their drugs to market
- Lifetree Clinical Research® to highlight services at the Bio International 2007 Convention
- Lifetree Clinical Research® to exhibit at the 26th Annual Scientific Meeting of the American Pain Society in Washington, DC
- Lifetree Clinical Research to participate in the 16th Annual Partnerships with CRO’s Conference
- Utah Pain Clinic takes spotlight in PBS documentary
- Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia
- Utah research company selected to test transdermal medicine administration
- National education campaign comes to St. George community
- Methadone related deaths on the rise – Six steps you should know
- Dr. Lynn R. Webster Pain Specialist to Appear on 20/20
- Local pain medicine specialist calls for zero unintentional deaths
- Community comes together to fight overdose deaths
- Dr. Lynn R Webster kicks off statewide education campaign
- Lifetree welcomes Douglas R. Jackson - VP of Finance
- Dr. Lynn R. Webster speaks on Pain in America: A Chronic Problem
- Dr. Lynn R. Webster introduces Zero Unintentional Deaths campaign
- Lifetree welcomes Dr. Robert A. Medve
- Media Coverage
- Dr. Webster interviewed by RT America on Pain Killer abuse and prescription drug classification. Watch the full interview.
- Dr. Webster quoted in recent Journal Sentinel article about proposed restrictions to vicodin and similar narcotic painkillers.
- Dr. Webster quoted in HealthDay article published in US News and World Report.
- Dr. Webster on NPR Morning Edition regarding proposed prescription drug changes for hydrocodone.
- Lifetree Community Health Fair Media Coverage
- Dr. Webster will be presenting “Optimizing the Benefit and Minimizing the Risk of Opioid Therapy for Chronic Pain†at the Providence Medical Center on 24 and 25 June 2010.
- Upcoming webinars from Dr. Webster on the topic of “Safe Prescribing of Opioids – Zero Unintentional Deathsâ€
- Dr Webster interviewed on addiction-intervention.com: Would Changes in Opioid Formulation Help Deter Abuse
- Dr Webster interviewed for Dr-Bob.org: New Licensing In Future For Opioid Prescribing
- View Dr Webster on KSL’s Studio 5 speaks on Opioid-Induced Constipation and research studies
- Dr Webster educates radio listeners about PHN, Qutenza, treatment options. 12 stations from Boston to Chicago to LA.
- Lifetree’s Robin Hollingsworth hosts an online informative tour on the web site of Qutenza®, a Neurogesx product.
- Dr Webster speaks on Emerging Solutions in Pain: Diffuse Trunk Radicular Pain in a Patient
- Dr Webster speaks on Emerging Solutions in Pain: How Often do you Order Urine Drug Tests?
- Liz Haycock, RN Appearance on Studio 5 for Sore Throat Study
- The Beacon Vol. III, Issue 23, December 1, 2009
- Dr. Webster quoted in ‘The News & Observer
- Lifetree clinical research recognized as one of Utah Business Magazine’s 50 Fastest Growing Companies
- Lifetree Clinical Research CEO Alice Jackson was featured on KSL’s Studio 5 on Monday, July 28th.
- Lifetree Clinical Research and Pain Clinic® and its Medical Director Lynn R. Webster, M.D., were featured in a national news story on CBS Evening News with Katie Couric the evening of Wednesday, Feb. 20, 2008.
- Lifetree Clinical Research and Pain Clinic® and its Medical Director Lynn R. Webster, M.D., were featured in a local news story on KUTV, Channel 2 News at 10 pm the evening of Wednesday, Feb. 20, 2008.
- Painkillers linked to sleep apnea
- Sleep apnea often seen with chronic opioid use
- New Tool for MDs in Fight Against Painkiller Abuse
- Pain Killers Could Induce Sleep Apnea
- Opioid-based pain medications may cause sleep apnea
- Study: Opioids May Cause Sleep Apnea Risk
- Opioid-based pain medications -- used to treat chronic pain -- may cause sleep apnea, suggest U.S. researchers.
- Pain patients at risk for sleep apnea
- Lifetree Clinical Research Now Utilizing New Technology to Evaluate the Abuse Liability of Test Medications
- Lifetree Clinical Research Facilitates New Drugs to Market
- Clinical research company expands by 10,000 sq. feet
- Technology leaders need employees and funds
- KSL 5's coverage of a study conducted at Lifetree Research
- Lynn R. Webster - publication: Expert Opinion, investigate drugs 2006, Informa Health Care Magazine
- Articles
- Evaluating the Efficacy, Safety, and Tolerability of Naloxegol in Patients With Opioid-induced Constipation
- Methylphenidate hydrochloride modified release (MPH-LA) in adults with attention deficit hyperactivity disorder (ADHD): Overall clinical improvement
- Dr. Webster featured in The Oncology Report: Eight Principles for Safe Opioid Prescribing
- Pain Ratings at the Thresholds are Necessary for Interpretation of Quantitative Sensory Testing. Muscle Nerve 2005 Volume: 32: 2, 179-84
- TRPV1 antagonistic analgesic effect: A randomized study of AZD1386 in pain following third molar extraction.
- Dr. Webster quoted in PainMedicineNews article: FDA Issues Draft Guidance for Abuse-Deterrent Opioid Development.
- FDA endorses restrictions on common painkiller. Read the latest news and articles with quotes from Dr. Webster.
- Article: Risk factors for drug diversion in a pain clinic patient population. Mary Jean Walker, DNP; Lynn R. Webster, MD
- Dr. Webster and Dr. Marin Grabois published in the November 2012 issue of The Journal of the American Medical Association (JAMA)
- Dr. Webster published in The Wall Street Journal: Making Opioid Drugs Less Alluring
- Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone
- Tolerability of NGX-4010 in conjunction with topical anesthetic formulations for the treatment of neuropathic pain.
- Sensor-Driven Position-Adaptive Spinal Cord Stimulation for Chronic Pain
- Preliminary Research 6b-Naltrexol, a Peripherally Selective Opioid Antagonist that Inhibits Morphine-Induced Slowing of Gastrointestinal Transit
- Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting.
- An Analysis of the Root Causes for Opioid-Related Overdose Deaths in the United States.
- Ending Unnecessary Opioid-Related Deaths: A National Priority
- System Dynamics Modeling as a Potentially Useful Tool in Analyzing Mitigation Strategies to Reduce Opioid Overdose Deaths
- A Review of Forensic Implications of Opioid Prescribing with Examples from Malpractice Cases Involving Opioid-Related Overdose
- Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users
- Mitigation of EtCO2 after Intravenous Injection of Morphine Sulfate and Naltrexone Hydrochloride
- Preventing Avoidable Opioid-Related Deaths Top Priority for Pain Medicine Field
- APS Posters 2011
- Long-Term Safety of Remoxy® (Extended- Release Oxycodone) in Patients with Moderate to Severe Chronic Osteoarthritis or Low Back Pain
- Posters from AAPM 2011
- Enhanced Bunionectomy Model as a Potential Tool for Early Decision-Making in the Development of New Analgesics
- Using an algorithm applied to urine drug screening to assess adherence to a hydrocodone regimen
- Considering the Risks of Benzodiazepines and Opioids Together
- Dr Webster published in the Journal of Pain and Symptom Management
- Postherpetic Neuralgia Treatment Study published in the The Journal of Pain
- Dr. Webster published in this month's issue of Journal of Opioid Management.
- Effects of the TRPV1 antagonist AZD1386 in patients with pain after third molar extraction
- A Multicenter, Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
- Troop deaths soar with prescriptions for war wounded
- Approaches to Improve Pain Relief While Minimizing Opioid Abuse Liability
- Dr. Webster featured in a Los Angeles Times article on chronic pain.
- Dr Webster Presents “Duration of treatment response to Qutenza™ (NGX-4010), a high concentration capsaicin patch, in patients with post-herpetic neuralgia.
- Tolerability of Treatment with NGX-4010 (Qutenza®) in Conjunction with Pre-Patch Topical Application of a Lidocaine 2.5%/Prilocaine 2.5% Anesthetic Cream
- Tolerability of NGX-4010 (Qutenza®) in Conjunction with Three Topical Anesthetic Formulations for the Treatment of Neuropathic Pain
- Select Medical-Legal Reviews of Unintentional Overdose Deaths
- Use of an Algorithm Applies to Urine Drug Screening to Assess Adherence to a Hydrocodone Regimen
- Use of an Algorithm Applied to Urine Drug Screening to Assess Adherence to an OxyContin® Regimen
- NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
- NKTR-118 Significantly Reverses Opioid-Induced Constipation
- PRISM study surgical technique poster for NANS
- Pharmacogenetics in Pain Management: the Clinical Need. Lynn R. Webster, MD
- Lifetree Clinical Research Hires New Clinical Research Pharmacist
- Drug hopes not to pass test. Alpharma developing tamper-resistant pain pill to help deter abuse.
- Alpharma developing tamper-resistant pain pill to curb abuse
- Dr. Webster manuscript has been accepted for publication in PAIN
- Pain Patients At Risk For Sleep Apnea
- Expert opinion PTI 821 sustained release Oxycodone using gel cap technology
- Safety first prescribing Methadone for pain management today
- Sleep disordered breathing and chronic opioid therapy
- Safety First: Prescribing Methadone for Pain ; Pain Management Today, February 2007
- More Data Needed in Methadone-Related Deaths:
- Physicians learning more about potential risk of Methadone/Opioids taken at night to worsen nighttime breathing problems.
- Lifetree Project Named “Best Poster Abstract†by the North American Neuromodulation Society (NANS).
- Results of phase 1 clinical trial shows excellent safety profile for IDDS
- Pain in America - A chronic problem: What you can do
- Dr. Lynn R. Webster to receive Utah Medical Association's Distinguished Initiative Award
- Pain in America - A Chronic Problem
- Lifetree Clinical Research® Kicks Off Community Education Campaign Series
- Lifetree Study Highlighted at American Pain Society Conference - SCRIP Magazine
- GSK reports positive Phase II results for Entereg in opiod-induced constipation
- Glaxo, Adolor Bowel Drug Works Well in Trial
- Lifetree Clinical Research® Study Provides Valuable Insight at American Pain Society Conference
- Letter from a patient
- Painful choices: Physicians challenged by quest to end suffering
- Questionaire Helps Screen Patients at Risk for Opioid Abuse: Pain Medicine News; Nov/Dec 2005
- Methadone Deaths;Journal of Opioid Management, September/October issue 2005
